{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:13:38Z","timestamp":1790133218199,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00391-019-01590-8","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T20:02:24Z","timestamp":1565812944000},"page":"457-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of antithrombotic drugs on bone health","Auswirkung von Antithrombotika auf den Knochen"],"prefix":"10.1007","volume":"53","author":[{"given":"G.","family":"Dadwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schulte-Huxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"issue":"3","key":"1590_CR1","doi-asserted-by":"publisher","first-page":"OC21","DOI":"10.7860\/JCDR\/2017\/23829.9483","volume":"11","author":"AH Abdulameer","year":"2017","unstructured":"Abdulameer\u00a0AH, Sulaiman\u00a0SABS, Kader\u00a0MBSA (2017) An assessment of osteoporotic conditions among users and non-users of warfarin: a case-control study. J\u00a0Clin Diagn Res 11(3):OC21\u2013OC24. \n                  https:\/\/doi.org\/10.7860\/JCDR\/2017\/23829.9483","journal-title":"J Clin Diagn Res"},{"issue":"7","key":"1590_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/eurheartj\/ehy813","volume":"40","author":"AN Mahmoud","year":"2019","unstructured":"Mahmoud\u00a0AN, Gad\u00a0MM, Elgendy\u00a0AY, Elgendy\u00a0IY, Bavry\u00a0AA (2019) Efficacy and safety of aspirin for primary prevention of cardiovascular events: a\u00a0meta-analysis and trial sequential analysis of randomized controlled trials. Eur Heart\u00a0J 40(7):607\u2013617. \n                  https:\/\/doi.org\/10.1093\/eurheartj\/ehy813","journal-title":"Eur Heart J"},{"issue":"2","key":"1590_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1055\/s-0038-1660790","volume":"6","author":"I Akkawi","year":"2018","unstructured":"Akkawi\u00a0I, Osteoporosis\u00a0ZH (2018) Current concepts. Joints 6(2):122\u2013127. \n                  https:\/\/doi.org\/10.1055\/s-0038-1660790","journal-title":"Joints"},{"issue":"1","key":"1590_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jbmr.5650110106","volume":"11","author":"DC Bauer","year":"1996","unstructured":"Bauer\u00a0DC, Orwoll\u00a0ES, Fox\u00a0KM, Vogt\u00a0TM, Lane\u00a0NE, Hochberg\u00a0MC, Stone\u00a0K, Nevitt\u00a0MC (1996) Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J\u00a0Bone Miner Res 11(1):29\u201335","journal-title":"J Bone Miner Res"},{"key":"1590_CR5","doi-asserted-by":"publisher","first-page":"3710959","DOI":"10.1155\/2017\/3710959","volume":"2017","author":"KY Chin","year":"2017","unstructured":"Chin\u00a0KY (2017) A review on the relationship between aspirin and bone health. J\u00a0Osteoporos 2017:3710959. \n                  https:\/\/doi.org\/10.1155\/2017\/3710959","journal-title":"J Osteoporos"},{"key":"1590_CR6","first-page":"HS3","volume":"12","author":"D Hulisz","year":"2006","unstructured":"Hulisz\u00a0D (2006) Drug-induced osteoporosis, effects of medications on bone density. Us Pharm 12:HS3\u2013HS6","journal-title":"Us Pharm"},{"issue":"2","key":"1590_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archinte.166.2.241","volume":"166","author":"BF Gage","year":"2006","unstructured":"Gage\u00a0BF, Birman-Deych\u00a0E, Radford\u00a0MJ, Nilasena\u00a0DS, Binder\u00a0EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 166(2):241\u2013246","journal-title":"Arch Intern Med"},{"issue":"8","key":"1590_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11606-016-3603-8","volume":"31","author":"O Gajic-Veljanoski","year":"2016","unstructured":"Gajic-Veljanoski\u00a0O, Phua\u00a0CW, Shah\u00a0PS, Cheung\u00a0AM (2016) Effects of long-term low-molecular-weight heparin on fractures and bone density in non-pregnant adults: a systematic review with meta-analysis. J\u00a0Gen Intern Med 31(8):947\u2013957. \n                  https:\/\/doi.org\/10.1007\/s11606-016-3603-8","journal-title":"J Gen Intern Med"},{"key":"1590_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fphar.2018.00348","volume":"9","author":"ZC Gu","year":"2018","unstructured":"Gu\u00a0ZC, Zhou\u00a0LY, Shen\u00a0L et al (2018) Non-vitamin K antagonist oral anticoagulants vs. Warfarin at risk of fractures: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 9:348. \n                  https:\/\/doi.org\/10.3389\/fphar.2018.00348","journal-title":"Front Pharmacol"},{"issue":"2","key":"1590_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jama.1965.03090020005001","volume":"193","author":"GC Griffith","year":"1965","unstructured":"Griffith\u00a0GC, Nichols\u00a0G Jr., Asher\u00a0JD et\u00a0al (1965) Heparin Osteoporosis. JAMA 193(2):91\u201394","journal-title":"JAMA"},{"issue":"4","key":"1590_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/jor.20090","volume":"24","author":"DJ Hak","year":"2006","unstructured":"Hak\u00a0DJ, Stewart\u00a0RL, Hazelwood\u00a0SJ (2006) Effect of low molecular weight heparin on fracture healing in a\u00a0stabilized rat femur fracture model. J\u00a0Orthop Res 24(4):645\u2013652","journal-title":"J Orthop Res"},{"issue":"2","key":"1590_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/bjs.4809","volume":"92","author":"AE Handschin","year":"2005","unstructured":"Handschin\u00a0AE, Trentz\u00a0OA, Hoerstrup\u00a0SP, Kock\u00a0HJ, Wanner\u00a0GA, Trentz\u00a0O (2005) Effect of low molecular weight heparin and Fondaparinux on human osteonblasts in vitro. Br J Surg 92(2):177\u2013183","journal-title":"Br J Surg"},{"issue":"4","key":"1590_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.injury.2007.10.035","volume":"39","author":"I Pountos","year":"2007","unstructured":"Pountos\u00a0I, Georgouli\u00a0T, Blokhuis\u00a0TJ, Chistoph Pape\u00a0H, Giannoudis\u00a0PV (2007) Pharmacological agents and impairment of fracture healing: what is the evidence? Injury 39(4):384\u2013394. \n                  https:\/\/doi.org\/10.1016\/j.injury.2007.10.035","journal-title":"Injury"},{"issue":"4","key":"1590_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2796.2012.02535","volume":"272","author":"NR Jorgensen","year":"2012","unstructured":"Jorgensen\u00a0NR, El Grove, Schwarz\u00a0P, Vestergaard\u00a0P (2012) Clopidogrel and the risk of osteoporotic fractures: a\u00a0nationwide cohort study. J\u00a0Intern Med 272(4):385\u2013393. \n                  https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02535","journal-title":"J Intern Med"},{"issue":"9","key":"1590_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00113-002-0419-2","volume":"105","author":"HJ Kock","year":"2002","unstructured":"Kock\u00a0HJ, Werther\u00a0S, Uhlenkott\u00a0H, Taeger\u00a0G (2002) Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model. Unfallchirurg 105(9):791\u2013796","journal-title":"Unfallchirurg"},{"key":"1590_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3710959","author":"C Kok-Yong","year":"2017","unstructured":"Kok-Yong\u00a0C (2017) A Review on the Relationship between Aspirin and Bone Health. Journal of Osteoporosis. Article ID 3710959. \n                  https:\/\/doi.org\/10.1155\/2017\/3710959","journal-title":"Journal of Osteoporosis"},{"issue":"11","key":"1590_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2017.1363","volume":"317","author":"WC Lau","year":"2017","unstructured":"Lau\u00a0WC, Chan\u00a0EW, Cheung\u00a0CL, Sing\u00a0CW, Man\u00a0KK, Lip\u00a0GY, Siu\u00a0CW, Lam\u00a0JK, Lee\u00a0AC, Wong\u00a0IC (2017) Association between Dabigatran vs warfarin and risk of Osteoporotic fractures among patients with nonvalvular atrial fibrillation. JAMA 317(11):1151\u20131158. \n                  https:\/\/doi.org\/10.1001\/jama.2017.1363","journal-title":"JAMA"},{"key":"1590_CR18","unstructured":"Laura S. Lehman, PharmD; Does Warfarin Use Affect Bone Health?"},{"issue":"7","key":"1590_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1517\/14656566.9.7.1169","volume":"9","author":"T Lindner","year":"2008","unstructured":"Lindner\u00a0T, Cockbain\u00a0AJ, El Masry\u00a0MA, Katonis\u00a0P, Tsiridis\u00a0E, Schizas\u00a0C, Tsiridis\u00a0E (2008) The effect of anticoagulant pharmacotherapy on fracture healing. Expert Opin Pharmacother 9(7):1169\u20131187. \n                  https:\/\/doi.org\/10.1517\/14656566.9.7.1169","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"1590_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00380-017-0950-2","volume":"32","author":"S Namba","year":"2017","unstructured":"Namba\u00a0S, Yamaoka Tojo\u00a0M, Kakizaki\u00a0R, Nemoto\u00a0T, Fujiyoshi\u00a0K, Hashikata\u00a0T, Kitasato\u00a0L, Hashimoto\u00a0T, Kameda\u00a0R, Meguro\u00a0K, Shimohama\u00a0T, Tojo\u00a0T, Ako\u00a0J (2017) Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels 32(8):977\u2013982. \n                  https:\/\/doi.org\/10.1007\/s00380-017-0950-2","journal-title":"Heart Vessels"},{"key":"1590_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fphar.2017.00821","volume":"8","author":"NR J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen\u00a0NR, Schwarz\u00a0P, Iversen\u00a0HK, Vestergaard\u00a0P (2017) P2Y12 receptor antagonist, Clopidogrel, does not contribute to risk of Osteoporotic fractures in stroke patients. Front Pharmacol 8:821. \n                  https:\/\/doi.org\/10.3389\/fphar.2017.00821","journal-title":"Front Pharmacol"},{"issue":"5","key":"1590_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1210\/jcem-66-5-1071","volume":"66","author":"P Pietschmann","year":"1988","unstructured":"Pietschmann\u00a0P, Woloszczuk\u00a0WS, Panzer\u00a0S, Kyrle\u00a0P, Smolen\u00a0J (1988) Decreased serum osteocalcin levels in Phenprocoumon-treated patients. J\u00a0Clin Endocrinol Metab 66(5):1071\u20131074","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1590_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/oxfordjournals.eurheartj.a059914","volume":"12","author":"H Resch","year":"1991","unstructured":"Resch\u00a0H, Pietschmann\u00a0P, Krexner\u00a0E, Woloszczuk\u00a0W, Willvonseder\u00a0R (1991) Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon. Eur Heart\u00a0J 12(3):439\u2013441","journal-title":"Eur Heart J"},{"issue":"2","key":"1590_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1756-185X.2009.01395.x","volume":"12","author":"Z Rezaieyazdi","year":"2009","unstructured":"Rezaieyazdi\u00a0Z, Falsoleiman\u00a0H, Khajehdaluee\u00a0M, Saghafi\u00a0M, Mokhtari-Amirmajdi\u00a0E (2009) Reduced bone density in patients on long-term warfarin. Int J Rheum Dis 12(2):130\u2013135. \n                  https:\/\/doi.org\/10.1111\/j.1756-185X.2009.01395.x","journal-title":"Int J Rheum Dis"},{"key":"1590_CR25","unstructured":"Rosen\u00a0HN, Drezner\u00a0MK, Mulder\u00a0JE Drugs that affect bone metabolism. \n                  https:\/\/www.uptodate.com\n                  \n                . Accessed 3 June 2019"},{"issue":"9527","key":"1590_CR26","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"P Sambrook","year":"2006","unstructured":"Sambrook\u00a0P, Cooper\u00a0C (2006) Osteoporosis. Lancet 367(9527):2010\u20132018","journal-title":"Lancet"},{"key":"1590_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00003086-200012000-00032","volume":"381","author":"JT Street","year":"2000","unstructured":"Street\u00a0JT, McGrath\u00a0M, O\u2019Regan\u00a0K et\u00a0al (2000) Thromboprophylaxis using a\u00a0low molecular weight heparin delays fracture repair. Clin Orthop Relat Res 381:278\u2013289","journal-title":"Clin Orthop Relat Res"},{"issue":"11","key":"1590_CR28","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/jbmr.1690","volume":"27","author":"S Syberg","year":"2012","unstructured":"Syberg\u00a0S, Brandao-Burch\u00a0A, Patel\u00a0JJ, Hajjawi\u00a0M, Arnett\u00a0TR, Schwarz\u00a0P et al (2012) Clopidogrel (Plavix), a\u00a0P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo. J\u00a0Bone Miner Res 27(11):2373\u20132386. \n                  https:\/\/doi.org\/10.1002\/jbmr.1690","journal-title":"J Bone Miner Res"},{"key":"1590_CR29","unstructured":"https:\/\/www.dv-osteologie.org\/dvo_leitlinien\/dvo-leitlinie-2017\n                  \n                ; accessed on 2 June 2019."}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-019-01590-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-019-01590-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-019-01590-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T23:42:27Z","timestamp":1597275747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-019-01590-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1007\/s00391-019-01590-8","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"assertion":[{"value":"24 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"G.\u00a0Dadwal, T.\u00a0Schulte-Huxel and G.\u00a0Kolb declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}